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A B S T R A C T
BACKGROUND AND PURPOSE: Recent trials have shown benefit of thrombectomy in patients selected by penumbral imaging
in the late (>6 hours) window. However, the role penumbral imaging is not clear in the early (0-6 hours) window. We sought
to evaluate if time to treatment modifies the effect of endovascular reperfusion in stroke patients with evidence of salvageable
tissue on CT perfusion (CTP).
METHODS: We retrospectively analyzed consecutive patients who underwent thrombectomy in a single center. Demographics,
comorbidities, National Institute of Health Stroke Scale (NIHSS), rtPA administration, ASPECTS, core infarct volume, onset to skin
puncture time, recanalization (mTICI IIb/III), final infarct volume were compared between patients with good and poor 90-day
outcomes (mRS 0-2 vs. 3-6). Multivariable logistic regression analyses were used to identify independent predictors of a good
(mRS 0-2) 90-day outcome.
RESULTS: A total of 235 patients were studied, out of which 52.3% were female. Univariate analysis showed that the groups
(early vs. late) were balanced for age (P = .23), NIHSS (P = .63), vessel occlusion location (P = .78), initial core infarct volume
(P = .15), and recanalization (mTICI IIb/III) rates (P = .22). Favorable outcome (mRS 0-2) at 90 days (P = .30) were similar.
There was a significant difference in final infarct volume (P = .04). Shift analysis did not reveal any significant difference in
90-day outcome (P = .14). After adjustment; age (P < .001), NIHSS (P = .01), recanalization (P = .008), and final infarct
volume (P < .001) were predictive of favorable outcome.
CONCLUSIONS: Penumbral imaging-based selection of patients for thrombectomy is effective regardless of onset time and
yields similar functional outcomes in early and late window patients.
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Recent clinical trials have confirmed the efficacy of endovas-
cular treatment in restoring blood flow for proximal intracra-
nial arterial occlusion within 6 hours of symptoms onset.1 This
treatment window was extended to 24 hours utilizing computed
tomography perfusion (CTP) and magnetic resonance imaging
(MRI) to select patients for thrombectomy based on the re-
sults of DAWN and DEFUSE III.2-4 Patients were selected for
endovascular treatment in this extended window after assess-
ment of infarct core and salvageable penumbra. In recent years,
penumbral imaging has become widely available providing
physiologic information. However, the role of advanced imag-
ing in selecting patients for mechanical thrombectomy (MT)
during the early (0-6 hours) window is unclear.5
Studies have suggested that assessment of infarct core and
salvageable penumbra constitutes valuable information inde-
pendent of onset time.6 Conventional imaging paradigm of
CT and CT angiography (CTA) might not provide a good as-
sessment of tissue status for decisions regarding MT. Despite
widespread use, utility of advanced imaging in selecting pa-
tients across the time continuum of early (0-6 hours) and late
(6-24 hours) window for thrombectomy has not been assessed.
Therefore, in this study we evaluated the impact of advanced
neuroimaging-based selection for thrombectomy on functional
outcomes across the time continuum. We hypothesized that
patients will have similar outcomes after MT in early and late
windows if selected by advanced imaging.
Methods
The retrospective cohort study was approved by our In-
stitutional Review Board, and Health Insurance Portability
and Accountability Act waiver of informed consent was
◦C 2020 by the American Society of Neuroimaging 315
granted. We adhered to the Strengthening the Reporting of
Observational studies in Epidemiology (STROBE) guidelines.7
Study Population
Consecutive stroke patients who received a multiparametric
CT brain imaging (noncontrast CT [NCCT] + CTP + CTA)
on presentation and underwent MT within 24 hours from last
known normal between January 2016 and June 2018 at our
comprehensive stroke center (CSC; Spectrum Health) were in-
cluded. Patient demographics, comorbidities, prestroke modi-
fied Rankin scale (mRS), and stroke etiology (using the Trial
of Org 10172 in Acute Stroke Treatment classification) after
completion of diagnostic evaluation and National Institute of
Health Stroke Scale (NIHSS) scores were assessed.
Imaging Protocol and Analysis
The Alberta Stroke Program Early CT Score (ASPECTS) was
calculated on NCCT.8 CTP was performed on a Discovery
General Electric (GE, Waukesha, WI) CT750 HD 64 row de-
tector scanner. Volumetric assessments of the ischemic core
and critically hypoperfused territory were performed using the
RAPID software (iSchemaView, Menlo Park, CA).9 Infarct core
was defined as relative decrease in cerebral blood flow to <30%
of normal. Critically hypoperfused tissue likely to infarct in
absence of reperfusion was defined as time-to-maximum of
residue function over 6 seconds (Tmax > 6 seconds). The tar-
get mismatch was defined as an absolute difference of 15 mL
or more between the Tmax > 6 seconds volume and the in-
farct core volume. Patients were selected for thrombectomy
based on the published criteria of EXTEND-IA and DEFUSE
III.6 Endovascular procedures were performed by experienced
interventionalists using commercially available stent retrievers
and aspiration catheters. Recanalization was defined as modi-
fied Thrombolysis In Cerebral Infarction (mTICI) IIb/III. The
final infarct volume was measured on the follow-up 24-48 hours
NCCT and diffusion weighted imaging (DWI) by ABC/2. This
method produces reliable results when compared to planimetry
and has good inter- and intrarater reliability.10
Statistical Analysis
The primary and secondary outcomes were good mRS (0-2)
score at 90 days and final infarct volume, respectively. Descrip-
tive statistics were used to summarize baseline characteristics
and outcome measures and were stratified by LKN to skin
puncture time. Summary statistics were calculated for the data.
Continuous variables were analyzed using a two-tailed t-test.
Normally distributed continuous variables are shown as mean
± SD (standard deviation). Non-normally distributed continu-
ous variables were transformed using either the log or inverse
hyperbolic sine procedure prior to analysis and are shown as
median (min-max). Categorical variables were analyzed using
the χ2 or Fisher’s Exact test and are shown as percentages (%
frequency). Baseline characteristics were stratified by mRS (0-2
vs. 3-6) in a univariate analysis. To maintain validity of regres-
sion for our study sample size; our model was limited to 8
variables for the regression analysis. Variables with a P < .01
on univariate analysis as well as LKN to skin puncture (variable
of interest) were used as independent variables in multivariable
logistic regression. Multivariable logistic regression model was
used to determine if LKN to skin puncture was independently
associated with good outcome (mRS 0-2) at 90 days. Secondary
analysis for independent predictors of excellent outcome (mRS
0-1) at 90 days was also evaluated with multivariable logistic
regression. The distribution on mRS scores at 3 months among
patients was also compared between the groups using the a ridit
score (shift) analysis.11 Significance was assessed at P < .05. All
statistical analyses were generated performed using IBM SPSS
Statistics, version 23 (Armonk, NY: IBM Corp).
Results
A total of 245 patients underwent thrombectomy between
January 2016 and June 2018 at our CSC. Patients who had re-
canalization after rtPA (tissue plasminogen activator) and prior
to thrombectomy were excluded from the analysis. A total of
235 patients were included in the final analysis. Demographics
and clinical characteristics of the study participants stratified by
LKN to skin puncture time in early (0-6 hours) and late (6-24
hours) windows are summarized in Table 1. On presentation to
the CSC, both groups were similar with regards to age, NIHSS,
hypertension, diabetes, and atrial fibrillation. However, late
window patients were predominantly female (61 vs. 47%).
There was no significant difference between the groups for pre-
stroke mRS. The etiology of stroke was mainly cardioembolic
and did not differ between the groups. ASPECTS, core infarct
core volume, vessel occlusion location, and rates of recanaliza-
tion (TICI IIb/III) were similar as well (Table 1). Patients in the
early window received intravenous thrombolysis significantly
more often than the late window patients. Univariate analyses
stratified by functional outcome (mRS 0-2 vs. 3-6) at 90 days
are summarized in Table 2. Age, NIHSS, female sex, diabetes,
atrial fibrillation, ASPECTS, core infarct volume, mL (CT-P),
rtPA administration, recanalization (mTICI IIb/III), and final
infarct volume were significant variables (P < .05). Onset
to Skin Puncture was not different between the two groups
(Table 2). In unadjusted analyses, good outcome (mRS 0-2) at
90 days was similar between the early and late window groups
(Table 3). However, final infarct volume was significantly
higher in the late window group (Table 3).
Results of the multivariable logistic regression are shown
in Table 4. Predictors of a good outcome at 90 days included
age, (odds ratio [OR]: .95; 95% confidence interval [CI]: .92-
.97), NIHSS (OR: .94; 95% CI: .89-.99), recanalization (OR:
7.63; 95% CI: 1.69-34.6), and final infarct volume (OR: .38;
95% CI: .27-.54). Accordingly, if all other factors were held
constant, patients who underwent recanalization were 7.6 times
more likely to achieve a good outcome (mRS 0-2) and every
10% increase in final infarct volume led to 8.8% reduction in
likelihood of achieving good outcome (mRS 0-2). LKN to skin
puncture was not an independent predictor of good outcome.
Predictors of excellent outcome (mRS 0-1) at 90 days included
age, (OR: .95; 95% confidence interval [CI]: .93-.98), NIHSS
(OR: .92; 95% CI: .87-.97), recanalization (OR: 6.24; 95% CI:
1.12-35.16), and final infarct volume (OR: .94; 95% CI: .92-
.97) (Table 5). LKN to skin puncture was not an independent
predictor of excellent outcome. Shift analysis of 90-day mRS
categories did not show any significant difference between the
groups (Fig 1; P = .14).
Discussion
Our study found that good functional outcome is not time
dependent if the patients are selected through advanced
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Table 1. Baseline Characteristics of the Studied Patient Population
Characteristics All Patients (n = 235)
EARLY WINDOW Onset to
Skin Puncture 0-6 hours
(n = 147)
LATE WINDOW Onset to
Skin Puncture 6-24 hours*
(n = 88) P value
Onset to Skin puncture† 271 (70-1700) 191 (70-360) 668 (365-1700) -
Age, years∗ 69.7 ± 15.9 70.7 ± 15.6 68.1 ± 16.4 .23
NIHSS∗ 17.3 ± 8.8 17.5 ± 8.6 16.9 ± 9.2 .63
Female sex 52.3% (123/235) 46.9% (69/147) 61.4% (54/88) .03
Hypertension 66.0% (155/235) 67.3% (99/147) 63.6% (56/88) .56
Diabetes 32.8% (77/235) 33.3% (49/147) 31.8% (28/88) .81
Atrial fibrillation 33.6% (79/235) 33.3% (49/147) 34.1% (30/88) .93
Prestroke mRS .19
0 67.2% (158/235) 61.9% (91/147) 76.1% (67/88)
1 15.7% (37/235) 19.0% (28/147) 10.2% (9/88)
2 10.2% (24/235) 11.6% (17/147) 8.0% (7/88)
3 6.0% (14/235) 6.1% (9/147) 5.7% (5/88)
4 .9% (2/235) 1.4% (2/147) 0% (0/88)
TOAST classification .99
Cardioembolic 47.7% (112/235) 48.3% (71/147) 46.6% (41/88)
Large artery 7.7% (18/235) 7.5% (11/147) 8.0% (7/88)
Atherosclerosis 40.4% (95/235) 40.1% (59/147) 40.9% (36/88)
Cryptogenic 4.3% (10/235) 4.1% (6/147) 4.5% (4/88)
ASPECTS 8.9 ± 1.2 9.0 ± 1.1 8.8 ± 1.2 .18
Core infarct volume, mL (CT-P)† 5.9 (0-256) 8.9 (0-256) 1.5 (0-119) .15
Symptomatic vessel .78
ICA 8.9% (21/235) 8.2% (12/147) 10.2% (9/88)
MCA 77.0% (181/235) 76.2% (112/147) 78.4% (69/88)
Basilar 5.1% (12/235) 5.4% (8/147) 4.5% (4/88)
Other 8.9% (21/235) 10.2% (15/147) 6.8% (6/88)
rtPA administration 39.1% (92/235) 55.1% (81/147) 12.5% (11/88) <.001
Recanalization (mTICI IIb/III) 81.7% (192/235) 84.4% (124/147) 77.3% (68/88) .22
ASPECTS = Alberta Stroke Program Early CT Score; CT-P = Computed tomography perfusion; ICA = Internal Carotid Artery; MCA = Middle Cerebral Artery;
mRS = modified Rankin scale; mTICI = modified Thrombolysis In Cerebral Infarction; NIHSS = National Institute of Health Stroke Scale; rtPA = recombinant tissue
plasminogen activator; TOAST = Trial of Org 10172 in Acute Stroke Treatment.
∗Mean ± standard deviation.
†Median (min-max).
Table 2. Univariate Analysis of 90-day Outcomes (Modified Rankin Scale (mRS) 0-2 vs. 3-6)
Characteristics All Patients (n = 235) mRS 0-2 (n = 82) mRS 3-6 (n = 153) P value
Age, years∗ 69.7 ± 15.9 64.0 ± 15.7 72.8 ± 15.2 <.001
NIHSS∗ 17.3 ± 8.8 13.1 ± 6.9 19.5 ± 8.9 <.001
Female sex 52.3% (123) 40.2% (33) 58.8% (90) .007
Hypertension 66.0% (155) 59.8% (49) 69.3% (106) .142
Diabetes 32.8% (77) 22.0% (18) 38.6% (59) .010
Atrial fibrillation 33.6% (79) 23.2% (19) 39.2% (60) .013
ASPECTS∗ 8.9 ± 1.2 9.2 ± 1.0 8.8 ± 1.2 .002
Core infarct volume, mL (CT-P)∗ 17.5 ± 28.7 8.1 ± 13.5 22.8 ± 33.2 <.001
rtPA administration 39.1% (92) 50.0% (41) 33.3% (51) .013
Onset to skin puncture∗ 381.6 ± 288.9 384.6 ± 303.4 380.1 ± 281.8 .91
Recanalization (mTICI IIb/III) 81.7% (192) 95.1% (78) 74.5% (114) <.001
Final infarct volume, mL∗ 55.0 ± 81.7 14.9 ± 27.8 76.9 ± 92.6 <.001
ASPECT = Alberta Stroke Program Early CT Score; CT-P = Computed tomography perfusion; mRS = Modified Rankin Scale; mTICI = modified thrombolysis in
cerebral infarction; n = Number of patients; NIHSS = National Institute of Health Stroke Scale; rtPA = Recombinant tissue plasminogen activator.
∗Mean ± standard deviation
imaging. Age, stroke severity (NIHSS), successful recanal-
ization (TICI IIb/III), and final infarct volume predicted
good functional outcome. LKN to skin puncture was not
predictive of outcome. Our findings are consistent with re-
cent studies emphasizing that collateral status and salvageable
penumbra are major predictors of tissue fate and functional
outcome.12-14
We selected patients for thrombectomy based on CTP pro-
file regardless of onset time. This raises the concern about the
utility of advanced neuroimaging in the early (0-6 hours) time
window and might lead to exclusion of otherwise suitable pa-
tients for MT.14 The American Heart Association (AHA) guide-
lines 2019 do not recommend perfusion imaging in the early
(0-6 hours) window.15 However, recent studies have suggested
that advanced neuroimaging-based selection for thrombec-
tomy nearly doubles the probability of good functional out-
comes as compared to minimalistic approach of CT/CTA-
based selection.16-18 All the patients in EXTEND-IA and 80%
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Puncture 0-6 hours LATE WINDOW Onset to Skin Puncture 6-24 hours P value
90 day mRS (0-2) 34.9% (82) 37.4% (55) 30.7% (27) .30
Final infarct volume, mL 21.6 (0-531) 20.5 (0-531) 35 (.4-450) .04
mRS = modified Rankin scale.
Data are shown as the median (min-max).
Fig 1. Modified Rankin Scale (mRS) at 90 days Ridit score (shift) analysis.
Table 4. Logistic Regression Analysis for Factors Associated with
Good Outcome (90 mRS 0-2)
Independent Variable OR 95% CI
Age∗ .95 (.92-.97)
Sex .66 (.32-1.38)
Onset to skin puncture .91 (.42-2.00)
NIHSS∗ .94 (.89-.99)
ASPECTS 1.24 (.88-1.74)
Core infarct volume (CT-P) 1.16 (.91-1.48)
Recanalization (mTICI IIb/III)∗ 7.46 (1.64-33.86)
Final infarct volume∗ .39 (.27-.55)
ASPECTS = Alberta Stroke Program Early CT Score; CI = Confidence inter-
val; CT-P = Computed tomography perfusion; mRS = Modified Rankin Scale;
mTICI = Modified thrombolysis in cerebral infarction; NIHSS = National Insti-
tute of Health Stroke Scale; OR = Odds ratio.
∗P < .05.
of the patients in SWIFT PRIME, were enrolled based on the
target mismatch profile on perfusion imaging.6 Both the tPA
and thrombectomy groups had twice as large good outcome as
compared to MR CLEAN.6 The treatment effect of thrombec-
tomy for good outcome was also about twice as large. However,
Table 5. Logistic Regression Analysis for Factors Associated with Ex-
cellent Outcome (90 mRS 0-1)




Core Infarct Volume (CT-P) 1.03 1.00-1.06
Recanalization (mTICI IIb/III)∗ 6.24 1.12-35.16
Final infarct volume∗ .94 .92-.97
ASPECTS = Alberta Stroke Program Early CT Score; CI = Confidence inter-
val; CT-P = Computed tomography perfusion; mRS = Modified Rankin Scale;
mTICI = Modified thrombolysis in cerebral infarction; NIHSS = National Insti-
tute of Health Stroke Scale; OR = Odds ratio. ∗P < .05.
it is important to note that selecting patients for thrombectomy
based on target mismatch profile in the early window can po-
tentially lead to exclusion of patients who would benefit from
thrombectomy despite unfavorable imaging.
Time-based eligibility is based on the concept of progression
from ischemia to infarction. However, time since last seen nor-
mal is a poor proxy for such determination. It has been noted
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that a significant number of patients with large vessel occlusion
(LVO) are “fast progressors” whose infarct growth is very sen-
sitive to time and collaterals fail early within the 6 hours.6 On
the other hand, “slow progressors” maintain a small ischemic
core and significant salvageable tissue beyond 6 hours despite
a persistent LVO by maintaining robust collaterals. The patho-
physiology of collateral blood flow regulation during LVO is
unclear. Moreover, strategies to slow down the progression of
infarct core are not well-established.19 Therefore, it is important
to assess the infarct core and salvageable brain-tissue prior to
thrombectomy as they are important prognostic factors inde-
pendent of LKN to skin puncture time.
Infarct core and penumbra can be assessed through multi-
ple modalities. Early ischemic changes can be assessed on CT
scan by the ASPECTS.20 However, inter-rater reliability, in-
farct core assessment, and prediction of good outcome utilizing
CT-ASPECTS are moderate.21 Salvageable penumbra due to
collaterals has been shown to predict outcome in patients un-
dergoing MT.22 Collaterals can be assessed in multiple ways.
CTA is commonly used to assess collateral status. However,
CTA can underestimate collateral status and caution is advised
in excluding patients with poor collaterals on CTA for MT.23
Multiphase CTA can be used to visualize this delayed collateral
flow.24 Multiphase CTA was used for patient selection in the
ESCAPE trial. However, a recent analysis showed that about
10% of these patients were misclassified based on multiphase
CTA and probably should have been excluded.25 CTP pro-
vides objective assessment of temporal and spatial collaterals
by capturing the entire transit of contrast bolus. It provides
estimation of ischemic core based on reduced cerebral blood
flow or cerebral blood volume. CTP has been shown to provide
accurate infarct core assessment using MRI-DWI as reference
standard.26 False overestimation of infarct core is rare.27 Re-
cent studies have shown that penumbral profile on CTP is a
better predictor of outcome as compared to ischemic changes
on NCCT and collaterals on CTA even within the early (0-6
hours) treatment window and is a better modality for patient
selection.25-28 Recent studies have suggested superiority of MRI
in assessing ischemic core as compared to CTP.29-31 However,
subgroup analyses from SWIFT-PRIME (early window) and
DEFUSE III (late window) studies did not show a difference
in outcome for CTP versus MRI selected patients.32-34 There-
fore, even though MRI is a superior modality; CTP is a reliable
alternative to DWI for assessing penumbra without significant
contraindications and superior accessibility.5
Time is still important and delays in treatment should be
avoided. A significant number of patients presenting in the ex-
tended window do not have favorable imaging profile.35 More-
over, those with favorable profile (slow progressors), become in-
eligible for treatment if not recanalized immediately after onset
and develop extensive infarction leading to poor outcomes.36,37
Patient presenting with favorable penumbral pattern on imag-
ing should receive thrombectomy expeditiously with care-
ful monitoring of imaging-to-skin puncture and imaging-to-
recanalization time metrics. Recent studies have highlighted
the need for improved work flow for prompt vascular access as
well as superior procedural skills in achieving recanalization in
an expedited manner.38-40
Our study has few limitations, which include the retrospec-
tive single -center nature, lack of data on patients excluded due
to unfavorable penumbral pattern, and exclusion of patients
with recanalization with thrombolysis prior to thrombectomy.
Final infarct volume was predictive of outcome and patients
in the late window (6-24 hours) had larger final infarct vol-
umes in this study. However, the overall outcome for both
good and excellent outcomes did not defer between the two
groups (early vs. late). This paradox could be explained by
the infarct volume calculation method used in our study which
despite being a valid approach; is still subject to errors. This
paradox will need further studies. These limitations can poten-
tially introduce physician practice and selection bias. Our large
sample size, robust neuroimaging analysis, long-term outcome
and multivariate analysis mitigate these limitations. Moreover,
our cohort reflects contemporary clinical practice.41
Tissue-based approach with penumbral imaging to select
patients for thrombectomy was effective regardless of onset time
in our study and yields similar functional outcomes in early
and late window patients. Advanced neuroimaging should be
considered for selection of thrombectomy candidates instead
of time from symptom onset. Further studies are needed to
validate our findings.
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